Powered by DeepSeek AI
BLOG
2 Sep 2025
Market View - September 02, 2025
Indian stocks rebounded on Monday after three consecutive days of losses, buoyed by strong 7.8% GDP growth and a US court ruling that eased market concerns about Trump's tariffs. While optimism around autos and consumer durables has grown, the Goods and Services Tax (GST) and borrowing pressures could dampen market sentiment.
Indian stocks closed higher on Monday, breaking a three-day losing streak, as stronger-than-expected GDP growth boosted investor sentiment. A US court ruling further eased market concerns, ruling that most of President Donald Trump's tariffs were illegal, though they will remain in effect until mid-October. The Bombay Stock Exchange's Sensex rose 554.84 points, or 0.70%, to 80,364.49, while the National Stock Exchange's Nifty rose 198.20 points, or 0.81%, to 24,625.05.
This suggests that the impact of tariffs is gradually fading, and our stock market is returning to normal.
The Nifty index is currently offering strong support around 24,400. Over the past few days, we've shared our investments in SYRMA and DRREDDY. SYRMA has risen from 720 to over 770, and most investors on our team have already seen returns exceeding 5%. Stay tuned for continued gains in this stock, as we continue to expand our gains. DRREDDY is also rising, so please be patient. Of course, if you haven't bought SYRMA or DRREDDY yet, you can still do so.
Indian stocks closed higher on Monday, breaking a three-day losing streak, as stronger-than-expected GDP growth boosted investor sentiment. A US court ruling further eased market concerns, ruling that most of President Donald Trump's tariffs were illegal, though they will remain in effect until mid-October. The Bombay Stock Exchange's Sensex rose 554.84 points, or 0.70%, to 80,364.49, while the National Stock Exchange's Nifty rose 198.20 points, or 0.81%, to 24,625.05.
This suggests that the impact of tariffs is gradually fading, and our stock market is returning to normal.
The Nifty index is currently offering strong support around 24,400. Over the past few days, we've shared our investments in SYRMA and DRREDDY. SYRMA has risen from 720 to over 770, and most investors on our team have already seen returns exceeding 5%. Stay tuned for continued gains in this stock, as we continue to expand our gains. DRREDDY is also rising, so please be patient. Of course, if you haven't bought SYRMA or DRREDDY yet, you can still do so.